| Product Code: ETC12588414 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Lung Cancer Therapeutic Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Lung Cancer Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Lung Cancer Therapeutic Market - Industry Life Cycle |
3.4 Austria Lung Cancer Therapeutic Market - Porter's Five Forces |
3.5 Austria Lung Cancer Therapeutic Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Austria Lung Cancer Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Austria Lung Cancer Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Austria Lung Cancer Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Austria |
4.2.2 Advancements in lung cancer therapeutic research and development |
4.2.3 Growing awareness about the importance of early detection and treatment of lung cancer |
4.3 Market Restraints |
4.3.1 High cost of lung cancer therapeutics |
4.3.2 Stringent regulatory requirements for approval of new therapies |
4.3.3 Limited access to specialized lung cancer treatment centers in certain regions of Austria |
5 Austria Lung Cancer Therapeutic Market Trends |
6 Austria Lung Cancer Therapeutic Market, By Types |
6.1 Austria Lung Cancer Therapeutic Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.4 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.6 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.1.7 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2 Austria Lung Cancer Therapeutic Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Kinase Inhibitors, 2021 - 2031F |
6.2.3 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Platinum-based Drugs, 2021 - 2031F |
6.2.4 Austria Lung Cancer Therapeutic Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021 - 2031F |
6.2.5 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.3 Austria Lung Cancer Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Austria Lung Cancer Therapeutic Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
7 Austria Lung Cancer Therapeutic Market Import-Export Trade Statistics |
7.1 Austria Lung Cancer Therapeutic Market Export to Major Countries |
7.2 Austria Lung Cancer Therapeutic Market Imports from Major Countries |
8 Austria Lung Cancer Therapeutic Market Key Performance Indicators |
8.1 Average survival rate of lung cancer patients in Austria |
8.2 Adoption rate of new lung cancer therapeutic options in the market |
8.3 Number of clinical trials for lung cancer therapies conducted in Austria |
9 Austria Lung Cancer Therapeutic Market - Opportunity Assessment |
9.1 Austria Lung Cancer Therapeutic Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Austria Lung Cancer Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Austria Lung Cancer Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Austria Lung Cancer Therapeutic Market - Competitive Landscape |
10.1 Austria Lung Cancer Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Austria Lung Cancer Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here